TD Cowen raised the firm’s price target on Regeneron (REGN) to $820 from $800 and keeps a Buy rating on the shares. The firm updated its model ahead of Q4 results.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REGN:
- REGN Earnings this Week: How Will it Perform?
- Regeneron: Earnings Reacceleration, Eylea HD and Dupixent Upside Drive Raised $916 Target and Outperform Rating
- Regeneron price target raised to $916 from $911 at Bernstein
- Regeneron: Dupixent-Led Growth, EYLEA Franchise Stabilization, and High-Value Pipeline Catalysts Underpin Buy Rating
- The Week That Was, The Week Ahead: Macro and Markets, Jan. 25